TransCode Therapeutics Leads Biotech Innovation with Targeted Oligonucleotide Delivery for Genetic Cancer
TransCode Therapeutics leads biotech with a proprietary delivery system that targets genetic tumors and metastases, promising safer, personalized cancer treatments and investor growth potential.
2 minutes to read